Michael J. Ambrogi, Chief Operating Officer at NovoCure Ltd (NVCR), sold 35,800 shares at $52.09 ($1.9M) on 2019-06-03, disclosed to the SEC on 2019-06-05.
Open-market sale of $1.9M NVCR by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $52.09 | 16,700 | $870K | 46.2% |
| 2 | $52.70 | 800 | $42K | 2.2% |
| 3 | $52.70 | 800 | $42K | 2.2% |
| 4 | $53.11 | 17,300 | $919K | 48.8% |
| 5 | $53.79 | 200 | $11K | 0.6% |
| Total | $52.62 avg | 35,800 |
| $1.9M |
| 100% |
| Filing → |
| NVCR | SELL | 2020-03-10 | $316K | — | Filing → |
| NVCR | SELL | 2020-03-02 | $386K | — | Filing → |
| NVCR | SELL | 2020-02-26 | $1.9M | — | Filing → |